EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Potentials of SGLT2 inhibitors in the treatment of diabetic rotator cuff diseases: a comprehensive review

Vivek Kumar Morya, Jun Lang, Mi-Kyung Kwak, Kyu-Cheol Noh

Clinics in Shoulder and Elbow · 2025-09-01 · 28 (3) · 383-393

DOI: 10.5397/cise.2024.00969 ↗

At a glance

Übersichtsarbeit in Clinics in Shoulder and Elbow, published on 2025-09-01. Written by Vivek Kumar Morya and 3 co-authors. Institution: Hallym University College of Medicine, Chuncheon, Korea. Cited 3 times so far (Crossref); 77 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Hallym University Research.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Degenerative rotator cuff disease (RCD) is a common musculoskeletal condition that disproportionately affects individuals with diabetes mellitus, leading to pain, functional impairment, and a reduced quality of life. Emerging evidence suggests that sodium-glucose co-transporter 2 inhibitors (SGLT2is), which are widely used for glycemic control in type 2 diabetes, offer additional musculoskeletal benefits beyond their metabolic effects. This review explores the potential protective role of SGLT2is in diabetic RCD by examining the epidemiological link between diabetes and tendon degeneration and evaluating the biological mechanisms through which SGLT2 is influence tendon health. These potential benefits include reducing inflammation, altering metabolism to a more tendon-friendly state, combating oxidative stress with ketones, encouraging a healing environment through macrophage modulation, and improving overall health via weight and blood sugar management. Preclinical and observational studies provide preliminary support for therapeutic benefits, although high-quality randomized clinical trials are lacking. Understanding the multifaceted role of SGLT2is in tendon biology will open new avenues for prevention and management of RCD, particularly in patients with metabolic disorders.

Subjects

Author keywords

Anti-inflammatoryGlucose uptakeInflammationRotator cuff diseaseSodium-glucose transporter 2 inhibitors

Authors and institutions

  • Hallym University College of Medicine, Chuncheon, Korea.
  • Department of Orthopedic Surgery, Hallym University Sacred Heart Hospital, Anyang, Korea.
  • Department of Endocrinology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.

Funding

  • Hallym University Research

Cite

APA

Morya, V. K., Lang, J., Kwak, M. K., & Noh, K. C. (2025). Potentials of SGLT2 inhibitors in the treatment of diabetic rotator cuff diseases: a comprehensive review. Clinics in Shoulder and Elbow, 28(3), 383-393. https://doi.org/10.5397/cise.2024.00969

Vancouver

Morya VK, Lang J, Kwak MK, Noh KC. Potentials of SGLT2 inhibitors in the treatment of diabetic rotator cuff diseases: a comprehensive review. Clinics in Shoulder and Elbow. 2025;28(3):383-393. doi:10.5397/cise.2024.00969

BibTeX
@article{Morya2025,
  author = {Morya, Vivek Kumar and Lang, Jun and Kwak, Mi-Kyung and Noh, Kyu-Cheol},
  title = {Potentials of SGLT2 inhibitors in the treatment of diabetic rotator cuff diseases: a comprehensive review},
  journal = {Clinics in Shoulder and Elbow},
  year = {2025},
  volume = {28},
  number = {3},
  pages = {383--393},
  doi = {10.5397/cise.2024.00969}
}
Start for free →